Guoliang Chen

Neutrophils as emerging immunotherapeutic targets: Indirect treatment of tumors by regulating the tumor immune environment based on a sialic acid derivative-modified nanocomplex platform.

Wenjing Wu, Mengyang Liu, Xinrong Liu, 2022, International journal of pharmaceutics.

Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy.

Mengyang Liu, Xinrong Liu, Yanzhi Song, 2019, Acta biomaterialia.

Sialic Acid Conjugate–Modified Liposomal Dexamethasone Palmitate Targeting Neutrophils for Rheumatoid Arthritis Therapy: Influence of Particle Size

Xinrong Liu, Yanzhi Song, Yihui Deng, 2021, AAPS PharmSciTech.

Sialic Acid Conjugate–Modified Liposomal Dexamethasone Palmitate Targeting Neutrophils for Rheumatoid Arthritis Therapy: Influence of Particle Size

Xinrong Liu, Yanzhi Song, Yihui Deng, 2021, AAPS PharmSciTech.

Structure-Directed Discovery of Potent Soluble Epoxide Hydrolase Inhibitors for the Treatment of Inflammatory Diseases.

B. Hammock, C. Morisseau, Jieru Wang, 2023, Journal of medicinal chemistry.

Minimalist Nanocomplex with Dual Regulation of Endothelial Function and Inflammation for Targeted Therapy of Inflammatory Vascular Diseases.

Xinrong Liu, Yanzhi Song, Yihui Deng, 2023, ACS nano.

Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids.

Xing Tang, Yu Zhang, Haibing He, 2022, International journal of pharmaceutics.

Neutrophils as Emerging Immunotherapeutic Targets: Indirect Treatment of Tumors by Regulating the Tumor Immune Environment Based on a Sialic Acid Derivative-Modified Nanocomplex Platform

Mengyang Liu, Xinrong Liu, Yanzhi Song, 2022, International journal of pharmaceutics.